Mergers and Acq...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Pandion Therapeutics
Mergers and Acquisitions
4/1/21 at 15:50
Share at
News editor
press@blackterminal.com
Merck has completed its acquisition of Pandion Therapeutics for $60 per share.
Pandion Therapeutics
Review
Source:
merck.com
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Yuzhuralzoloto reduced gold production by 11%
8/29/24
UGLD
Magnit reported for 6 months of 2024 by RAS
8/29/24
MGNT
ChKPZ reported for 6 months of 2024 by IFRS
8/29/24
CHKZ
UWC reported for 6 months of 2024 under IFRS
8/29/24
UWGN
FGC-Rosseti reported for 6 months of 2024 by IFRS
8/29/24
FEES
Yuzhuralzoloto reported for 6 months of 2024 by IFRS
8/29/24
UGLD
Stavropolenergosbyt reported for 6 months of 2024 by IFRS
8/29/24
STSB
TNS Energy Yaroslavl reported for 6 months of 2024 by IFRS
8/29/24
YRSB
Gazprom reported for 6 months of 2024 by IFRS
8/29/24
GAZP
Gazprom launched the fourth line of the Amur Gas Processing Plant
8/29/24
GAZP
«
Previous
11
12
13
14
15
16
17
18
19
20
»
Next
BlackTerminal.com 2016 - 2024.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)